Significance of mastocytemia in cats

Veterinary Clinical Pathology

Volumn 42, Issue 1, 2013, Pages 4-10

  Piviani, Martina ^a   Walton, Raquel M ^a   Patel, Reema T ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Blood smear; Buffy coat; Feline; Mast cell; Visceral mast cell tumor

Indexed keywords

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; CAT; CAT DISEASE; DIFFERENTIAL DIAGNOSIS; FEMALE; MALE; MAST CELL; MASTOCYTOMA; PATHOLOGY; RETROSPECTIVE STUDY;

ANIMALS; CAT DISEASES; CATS; DIAGNOSIS, DIFFERENTIAL; FEMALE; MALE; MAST CELLS; MASTOCYTOMA; RETROSPECTIVE STUDIES;

ANIMALIA; CANIS FAMILIARIS; FELIDAE;

EID: 84874722178     PISSN: 02756382     EISSN: 1939165X     Source Type: Journal    
DOI: 10.1111/vcp.12021     Document Type: Article

References (19)

1. Skeldon NC, Gerber KL, Wilson RJ, Cunnington SJ. Mastocytaemia in cats: prevalence, detection and quantification methods, haematological associations and potential implications in 30 cats with mast cell tumours. J Feline Med and Surg. 2010;12:960-966.
2. Garret LD, Craig CL, Szladovitz B, Chun R. Evaluation of buffy coat smears for circulating mast cells in healthy cats and ill cats without mast cell tumour-related disease. J Am Vet Med Assoc. 2007;231:1685-1687.
3. Thamm DH, Vail DM. Mast cell tumors. In: Withrow SJ, Vail DV. Small Animal Clinical Oncology. 4th ed. St Louis, MO: Saunders-Elsevier; 2007:420.
4. McManus PM. Frequency and severity of mastocytemia in dogs with and without mast cell tumours: 120 cases (1995-1997). J Am Vet Med Assoc. 1999;215:355-357.
5. Stockham SL, Basel DL, Schmidt DA. Mastocytemia in dogs with acute inflammatory diseases. Vet Clin Pathol. 1986;15:16-21.
6. Pohlman LM. Basophils, mast cells, and their disorders. In: Weiss DJ, Wardrop KJ. Schalm's Veterinary Hematology. 6th ed. Ames, IA: Blackwell Publishing; 2010:291.
7. Rassnick KM, Williams LE, Kristal O, et al. Lomustine for treatment of mast cell tumours in cats: 38 cases (1999-2005). J Am Vet Med Assoc. 2008;232:1200-1205.
8. Woldemeskel M, Rajeev S. Mast cells in canine cutaneous hemangioma, hemangiosarcoma and mammary tumors. Vet Res Commun. 2010;34:153-160.
9. Khazaie K, Blatner NR, Khan MW, et al. The significant role of mast cells in cancer. Cancer Metastasis Rev. 2011;30:45-60.
10. Soucek L, Lawlor ER, Soto D, Shchors K, Swigart LB, Evan GI. Mast cells are required for angiogenesis and macroscopic expansion of Myc-induced pancreatic islet tumors. Nat Med. 2007;13:1211-1218.
11. Fukushima N, Satoh T, Sano M, Tokunaga O. Angiogenesis and mast cells in non-Hodgkin's lymphoma: a strong correlation in angioimmunoblastic T-cell lymphoma. Leuk Lymphoma. 2001;42:709-720.
12. Ribatti D, Vacca A, Marzullo A, et al. Angiogenesis and mast cell density with tryptase activity increase simultaneously with pathological progression in B-cell non-Hodgkin's lymphomas. Int J Cancer. 2000;85:171-175.
13. Wasiuk A, De Vries VC, Hartmann K, Roers A, Noelle RJ. Mast cells as regulators of adaptive immunity to tumours. Clin Exp Immunol. 2009;155:140-146.
14. Galinsky DS, Nechushtan H. Mast cells and cancer - no longer just basic science. Crit Rev Oncol Hematol. 2008;68:115-130.
15. Hauswirth AW, Fodinger M, Fritz M, et al. Indolent systemic mastocytosis associated with atypical small lymphocytic lymphoma: a rare form of concomitant lymphoproliferative disorder. Hum Pathol. 2008;39:917-924.
16. Du S, Rashidi HH, Dzung TL, Kipps TJ, Broome HE, Wang HY. Systemic mastocytosis in association with chronic lymphocytic leukemia and plasma cell myeloma. Int J Clin Exp Pathol. 2010;3:448-457.
17. Motwani P, Kocoglu M, Lorsbach RB. Systemic mastocytosis in association with plasma cell dyscrasias: report of a case and review of the literature. Leuk Res. 2009;33:856-859.
18. Sotlar K, Saeger W, Stellmacher F, et al. "Occult" mastocytosis with activating c-kit point mutation evolving into systemic mastocytosis associated with plasma cell myeloma and secondary amyloidosis. J Clin Pathol. 2006;59:875-878.
19. Fritsche-Polanz R, Fritz M, Huber A, et al. High frequency of concomitant mastocytosis in patients with acute myeloid leukemia exhibiting the transforming KIT mutation D816V. Mol Oncol. 2010;4:335-346.